Literature DB >> 18822346

Evidence that TRPC1 is involved in hippocampal glutamate-induced cell death.

K Lakshmi Narayanan1, Krithi Irmady, Srinivasa Subramaniam, Klaus Unsicker, Oliver von Bohlen und Halbach.   

Abstract

Massive neuronal activation by glutamate can result in an excessive rise in cytoplasmic calcium, a process ultimately leading to neuronal death. We have investigated the role of the transient receptor potential channel 1 (TRPC1) in mediating glutamate-induced neuron death. We show that 2-APB (a blocker of store-operated Ca2+ entry) dramatically reduces glutamate-induced cell death in hippocampal organotypic slice cultures and that glutamate-induced toxicity is accompanied by an increase in TRPC1 expression. RNAi mediated knock-down ofTRPC1 in slice cultures prevented glutamate-induced cell death, indicating that TRPC1 plays a prominent role in calcium entry following exposure to glutamate. Thus, TRPC1 may represent a promising target for pharmacological interventions to prevent or reduce glutamate-induced neuronal damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822346     DOI: 10.1016/j.neulet.2008.09.034

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  TRPC channels and their implication in neurological diseases.

Authors:  Senthil Selvaraj; Yuyang Sun; Brij B Singh
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

2.  Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death.

Authors:  Archana Nagarajan; Ye Ning; Kaja Reisner; Zafir Buraei; Jan Petter Larsen; Oliver Hobert; Maria Doitsidou
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

3.  Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment.

Authors:  Jun Wu; Hsin-Pei Shih; Vladimir Vigont; Lori Hrdlicka; Len Diggins; Carol Singh; Matt Mahoney; Richard Chesworth; Gideon Shapiro; Olga Zimina; Xuesong Chen; Qingqing Wu; Lyubov Glushankova; Michael Ahlijanian; Gerhard Koenig; Galina N Mozhayeva; Elena Kaznacheyeva; Ilya Bezprozvanny
Journal:  Chem Biol       Date:  2011-06-24

4.  Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice.

Authors:  Maximilian Peters; Victoria Trembovler; Alexander Alexandrovich; Moshe Parnas; Lutz Birnbaumer; Baruch Minke; Esther Shohami
Journal:  J Neurotrauma       Date:  2012-11-16       Impact factor: 5.269

5.  Modes of Neuronal Calcium Entry and Homeostasis following Cerebral Ischemia.

Authors:  J L Cross; B P Meloni; A J Bakker; S Lee; N W Knuckey
Journal:  Stroke Res Treat       Date:  2010-11-01

6.  Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.

Authors:  Jun Wu; Daniel Ryskamp; Lutz Birnbaumer; Ilya Bezprozvanny
Journal:  J Huntingtons Dis       Date:  2018

7.  Role of transient receptor potential channel 1 (TRPC1) in glutamate-induced cell death in the hippocampal cell line HT22.

Authors:  K Lakshmi Narayanan; Srinivasa Subramaniam; C Peter Bengston; Krithi Irmady; Klaus Unsicker; Oliver von Bohlen und Halbach
Journal:  J Mol Neurosci       Date:  2013-11-16       Impact factor: 3.444

8.  Chronic Treatment with Anti-bipolar Drugs Down-Regulates Gene Expression of TRPC1 in Neurones.

Authors:  Ting Du; Yan Rong; Rui Feng; Alexei Verkhratsky; Liang Peng
Journal:  Front Cell Neurosci       Date:  2017-01-10       Impact factor: 5.505

9.  TNFα induces Ca2+ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells.

Authors:  Jianjun Zhu; Mingpeng Jin; Jiaojiao Wang; Hui Zhang; Yousheng Wu; Deyang Li; Xiaoying Ji; Hushan Yang; Chun Yin; Tingting Ren; Jinliang Xing
Journal:  J Exp Clin Cancer Res       Date:  2018-03-05

10.  The role of canonical transient receptor potential channels in seizure and excitotoxicity.

Authors:  Fang Zheng; Kevin D Phelan
Journal:  Cells       Date:  2014-04-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.